(IN BRIEF) AstraZeneca has finalized its equity investment with Cellectis, a clinical-stage biotechnology firm, following a successful research collaboration agreement announced in November 2023. This partnership aims to harness Cellectis’ gene editing technologies to design up to 10 novel cell … Read the full press release →
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, Cell and Gene Therapy Development, Cellectis, France, investment, partnership
Load more...
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
Green Light for Henri Hotel, Restaurants and Shops in the “Alter Fischereihafen” (Old Fishing Port) in Cuxhaven, opening Summer 2026
Digi Communications N.V. reports consolidated revenues and other income of EUR 447 million, adjusted EBITDA (excluding IFRS 16) of EUR 140 million for Q1 2024
Digi Communications finalizes EUR 117M export credit facilities for telecom network expansion in Romania and Portugal. Digi Spain also secures EUR 50M bridge facility with Banco Santander for working capital
Digi Communications N.V. to host its general shareholders meeting on June 25, 2024, to discuss key topics including the 2023 Annual Report and dividend distribution
Digi Communications NV announces Investors Call for the presentation of the Q1 2024 Financial Results
Digi Communications N.V. proposes a dividend increase for 2023
Digi Communications N.V. announces the availability of the Romanian version of the 2023 Annual Report
Digi Communications N.V. announces the availability of the 2023 Annual Report
BevZero Spain Enhances Sustainability Efforts with Installation of Solar Panels at Production Facility
Digi Communications N.V. announces share transaction made by an Executive Director of the Company with class B shares
BevZero South Africa Achieves FSSC 22000 Food Safety Certification
Digi Spain Enters Agreement to Sell FTTH Network to International Investors for Up to EUR 750 Million
Patients as Partners® Europe Announces the Launch of 8th Annual Meeting with 2024 Keynotes and Topics
Cybersecurity across Europe in the last quarter (1 Dec 2023 – 1 Mar 2024)
Hamburg-based LogTech company driveMybox expands to Hungary
What’s new in cancer care across Europe in early 2024
The European companies at MWC Barcelona 2024: AI, 5G, VR, XR, Cybersecurity, etc.
Digi Communications NV 2023 Preliminary Financial Results
THE LATEST ON QUANTUM COMPUTING IN EUROPE
DIGI COMMUNICATIONS NV INVESTORS CALL ON 2023 PRELIMINARY FINANCIAL RESULTS
AI IN JAN 2024 ACROSS EUROPE
LENSA СТЪПВА НА БЪЛГАРСКИЯТ ПАЗАР
CRIANDO O FUTURO: DESENVOLVIMENTO DA AENO NO MERCADO DE CONSUMO EM PORTUGAL
DIGI COMMUNICATIONS N.V. 2024 FINANCIAL CALENDAR
CDP INDUSTRY UPDATE JAN 2024
ECARSTRADE ANNONCE DIRK VAN ROOST AU POSTE DE DIRECTEUR ADMINISTRATIF ET FINANCIER
NEXT-GEN DEALCOHOLIZATION TECHNOLOGY
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
KUKA LAUNCHES VERSATILE KR FORTEC INDUSTRIAL ROBOT WITH EXTENDED ARM
VIRTUAL ASSISTANT WITH GENERATIVE AI FOR HYPER-PERSONALIZED IN-CAR EXPERIENCE
